Ceva Animal Health has rebranded its potent, long-lasting analgesic, Vetergesic, with new packaging following the company’s successful integration of Sogeval Animal Health.

The move follows Ceva’s appointment of a new, dedicated Vetergesic manufacturing site and increased stock-holding facilities.

This will guarantee a continuous long-term supply of Vetergesic in both a convenient 10ml vial for use in dogs, cats and horses and a 1ml single dose preparation for cats and dogs.

Vetergesic is a centrally-acting, potent, long-lasting analgesic. It contains buprenorphine as its active ingredient and is recommended for use alongside NSAIDs for the management of mild to moderately painful surgical and traumatic conditions.

According to Ceva, the product delivers a longer duration of analgesic effect than other veterinary opiates (Ceva Study MPK/375 BO/0302 – available on request).

To celebrate the rebrand, Ceva has launched a spring offer on its entire analgesic product range. For every two packs of Vetergesic, Carprodyl F or Dolagis purchased, veterinary practices will receive one pack free. For every four packs of Meloxidyl purchased veterinary practices will receive one pack free. 

Over and above the offer – which runs until the end of April – practices will also be able to take advantage of ongoing rebates through the new CevaSave Rebate Programme.

  • Vetergesic is a Schedule 3 controlled drug.
  • For further information, to book lunch meetings or enquire about upcoming CPD events, contact your local Ceva territory manager, email analgesics-group@ceva.com or call 01494 781510.
View your activity >

Leave a Reply

Be the First to Comment!

Notify of